MSD BRAVECTO PLUS LARGE CAT 500mg

R331,21 excl.

For cats suffering from, or at risk of, mixed ecto- and endoparasitic infestations.

Description

Reg. No. G4408 (Act 36/1947)

Namibia Reg. No. V22/18.1.8/1505 [NS0]

For Small Cats

For Medium Cats

For Large Cats

INDICATIONS

For cats suffering from, or at risk of, mixed ecto- and endoparasitic infestations.

  • For the treatment of tick and flea infestations in cats. Bravecto® Plus is a systemic insecticide and acaricide that provides immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus, Ixodes scapularis, Rhipicephalus sanguineus and Haemaphysalis spp.) killing activity for 3 months.
  • For the treatment of ear mites (Otodectes cynotis) in cats.
  • For the prevention of heartworm disease caused by Dirofilaria immitis for 3 months.
  • For the treatment of infestations of intestinal roundworm (Toxocara cati; fourth stage larvae, immature adults and adults) and hookworm (Ancylostoma tubaeforme; fourth stage larvae, immature adults and adults).

Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

Bravecto® Plus can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

CAUTION

STORAGE

  • Store at or below 25 °C.
  • The pipettes should be kept in the outer packaging to prevent solvent loss or moisture uptake.
  • The sachets should only be opened immediately prior to use.
  • Do not use this veterinary medicinal product after the expiry date which is stated on the container label.

COMPOSITION

Each 1 mℓ of Bravecto® Plus contains 280 mg fluralaner and 14 mg moxidectin.

Each pipette of Bravecto® Plus delivers the following:

Bravecto® Plus Pipette content (mℓ) Fluralaner (mg) Moxidectin (mg)
Small cats 1,2 to 2,8 kg 0,4 112,5 5,6
Medium cats > 2,8 to 6,25 kg 0,89 250 12,5
Large cats > 6,25 to 12,5 kg 1,79 500 25

Excipient(s):

Butylhydroxytoluene 1,07 mg/mℓ.